Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: GC Assay Method for Volatile APIs – V 2.0

Posted on By

Analytical Method Development: GC Assay Method for Volatile APIs – V 2.0

SOP for Assay Method Development of Volatile APIs Using Gas Chromatography


Department Analytical Method Development
SOP No. SOP/AMD/086/2025
Supersedes SOP/AMD/086/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines the methodology for developing a gas chromatographic (GC) assay for volatile active pharmaceutical ingredients (APIs). It ensures accurate quantification, sensitivity,

and regulatory compliance using validated GC parameters and techniques.

2. Scope

This procedure is applicable to the Analytical Method Development (AMD) department and is intended for APIs that are volatile at ambient or elevated temperatures and require GC-based analysis for assay determination.

3. Responsibilities

  • Analytical Chemist: Executes method development, sample preparation, and chromatographic analysis.
  • Method Reviewer: Ensures scientific and regulatory soundness of the developed GC assay method.
  • QA Officer: Verifies all documentation, calibration, and suitability checks.
  • Head – AMD: Approves finalized assay method for validation and routine use.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that all GC assay methods for volatile APIs meet the validation requirements set by ICH Q2(R1) and are suitable for intended use.

See also  Analytical Method Development: System Suitability Limits Design for HPLC - V 2.0

5. Procedure

5.1 Selection of Analytical Technique

  1. Identify APIs with volatility above 40°C or vapor pressure >10 mmHg.
  2. Evaluate GC compatibility and select direct injection or headspace based on matrix and stability.
  3. Document rationale in Annexure-1: Technique Justification Log.

5.2 Instrument Configuration

  1. Instrument: GC with Flame Ionization Detector (FID).
  2. Column: DB-1 or equivalent non-polar column, 30 m × 0.25 mm ID × 0.25 µm film thickness.
  3. Carrier Gas: Helium at constant flow (1 mL/min).
  4. Oven Program: 50°C (1 min) to 250°C at 10°C/min.
  5. Detector and Injector Temperatures: 250°C and 220°C, respectively.
  6. Record in Annexure-2: GC System Setup Log.

5.3 Sample and Standard Preparation

  1. Standard: Prepare in DMSO, DMF, or IPA at 100% concentration level of label claim.
  2. Sample: Weigh accurately (e.g., 100 mg) into a 10 mL volumetric flask, add diluent, and vortex.
  3. If needed, analyze freshly due to evaporation risk.
  4. Document all preparation in Annexure-3: Sample Preparation Log.

5.4 Calibration and Linearity

  1. Prepare standard solutions at 50%, 80%, 100%, 120%, and 150% of target concentration.
  2. Inject in duplicate and plot concentration vs. peak area.
  3. Acceptance Criteria:
    • R² ≥ 0.995
    • %RSD ≤ 2% for replicate injections
  4. Document in Annexure-4: Linearity and Calibration Report.
See also  Analytical Method Development: Mass Spectral Fragmentation Analysis SOP - V 2.0

5.5 Assay Calculation

  1. Calculate API assay using:
    Assay (%) = (Area_sample / Area_standard) × (Conc_standard / Conc_sample) × 100
    
  2. Include dilution factors and response factors if applicable.
  3. Summarize results in Annexure-5: GC Assay Calculation Sheet.

5.6 System Suitability and Specificity

  1. Inject standard solution six times and calculate:
    • %RSD of peak area ≤ 2%
    • RT consistency (SD ≤ 0.05 min)
  2. Perform blank and placebo injection to ensure no interfering peaks.
  3. Overlay chromatograms for confirmation and record in Annexure-6: System Suitability Report.

5.7 Method Robustness

  1. Assess method response by varying:
    • Oven ramp rate ±2°C/min
    • Injector temperature ±5°C
    • Split ratio (if applicable)
  2. Acceptance: Assay results within ±2% of original.
  3. Document findings in Annexure-7: Robustness Study Log.

6. Abbreviations

  • API: Active Pharmaceutical Ingredient
  • GC: Gas Chromatography
  • FID: Flame Ionization Detector
  • RT: Retention Time
  • RSD: Relative Standard Deviation
  • SOP: Standard Operating Procedure

7. Documents

  1. Technique Justification Log – Annexure-1
  2. GC System Setup Log – Annexure-2
  3. Sample Preparation Log – Annexure-3
  4. Linearity and Calibration Report – Annexure-4
  5. GC Assay Calculation Sheet – Annexure-5
  6. System Suitability Report – Annexure-6
  7. Robustness Study Log – Annexure-7

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <621> – Chromatography
  • USP <731> – Loss on Drying (if applicable)
  • FDA Guidance – Analytical Procedures and Methods Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Technique Justification Log

API Boiling Point (°C) Justification for GC
Ethyl acetate 77 Volatile, suitable for FID detection

Annexure-2: GC System Setup Log

Instrument Column Detector Carrier Gas Oven Program
Agilent 7890 DB-1, 30 m FID He 50°C to 250°C @ 10°C/min

Annexure-3: Sample Preparation Log

ID Sample Type Weight (mg) Diluent Prepared By
API-001 Volatile API 100 DMSO Rajesh Kumar

Annexure-4: Linearity and Calibration Report

Level (%) Concentration (ppm) Peak Area Status
100% 1000 145623 Pass

Annexure-5: GC Assay Calculation Sheet

Sample ID Area Sample Area Standard Result (%)
API-001 143220 145623 98.4%

Annexure-6: System Suitability Report

Injection No. Peak Area RT (min)
1 145623 5.47
2 145481 5.46

Annexure-7: Robustness Study Log

Parameter Changed Value Assay (%) Deviation
Injector Temp 225°C 97.8% -0.6%

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Integrated assay calculation logic and robustness annexures Annual SOP Review
See also  Analytical Method Development: SOP for HPTLC Method Development - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Biosimilars: SOP for Online Sensor Calibration in Bioreactor Operations – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Dispensing Materials for Intraosseous Injections – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version